Anticancer Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Highlevel overall survival OS results from the TROPIONLung01 Phase III trial which previously met the dual primary endpoint of progressionfree survival PFS numerically favoured datopotamab deruxtecan DatoDXd compared to docetaxel in the overall trial population of patients with locally advanced or metastatic nonsmall cell lung cancer NSCLC treated with at least one prior line of therapy.

Cavity- and cancer-preventing vitamin D isn't the only reason to spend time in the sun. Here are 5 benefits of sunlight you probably never knew about.

EXCLUSIVE: While air pollution's link to lung conditions is well known, it's also directly implicated in cancer, including breast and prostate, according to the review of 27 studies.

An expert has revealed how a Mediterranean-style diet could be of help in fighting the effects of air pollution in the body.

Application based on results from the TROPION-Lung01 phase 3 trial If approved, Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan may be the first TROP2 directed antibody drug conjugate...